Secondary plasma cell leukaemia treated with single agent venetoclax

被引：13

作者：

Glavey, Siobhan V. ^{[1
,2
]}

Flanagan, Lyndsey ^{[3
]}

Bleach, Rachel ^{[3
]}

Kelly, Claire ^{[1
,2
]}

Quinn, John ^{[1
,2
]}

Ni Chonghaile, Triona ^{[3
]}

Murphy, Philip ^{[1
,2
]}

机构：

[1] Royal Coll Surgeons Ireland, Dept Haematol, Dublin, Ireland

[2] Beaumont Hosp, Dublin, Ireland

[3] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin, Ireland

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 190卷 / 04期

关键词：

leukaemia therapy; multiple myeloma; BCL-2; myeloma theraphy; leukaemia cytogenetics; BCL-2; INHIBITION; TRANSLOCATIONS; THERAPY;

D O I：

10.1111/bjh.16858

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E242 / E245

页数：4

共 12 条

[1] Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia:: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytogenetique Hematologique [J].

Avet-Loiseau, H ;

Daviet, A ;

Brigaudeau, C ;

Callet-Bauchu, E ;

Terré, C ;

Lafage-Pochitaloff, M ;

Désangles, F ;

Ramond, S ;

Talmant, P ;

Bataille, R .

BLOOD, 2001, 97 (03) :822-825

[2] Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199 [J].

Chonghaile, Triona Ni ;

Roderick, Justine E. ;

Glenfield, Cian ;

Ryan, Jeremy ;

Sallan, Stephen E. ;

Silverman, Lewis B. ;

Loh, Mignon L. ;

Hunger, Stephen P. ;

Wood, Brent ;

DeAngelo, Daniel J. ;

Stone, Richard ;

Harris, Marian ;

Gutierrez, Alejandro ;

Kelliher, Michelle A. ;

Letai, Anthony .

CANCER DISCOVERY, 2014, 4 (09) :1074-1087

[3] The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma [J].

Fonseca, R ;

Debes-Marun, CS ;

Picken, EB ;

Dewald, GW ;

Bryant, SC ;

Winkler, JM ;

Blood, E ;

Oken, MM ;

Santana-Dávila, R ;

González-Paz, N ;

Kyle, RA ;

Gertz, MA ;

Dispenzieri, A ;

Lacy, MQ ;

Greipp, PR .

BLOOD, 2003, 102 (07) :2562-2567

[4] Combination therapy incorporating Bcl-2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14) [J].

Gonsalves, Wilson I. ;

Buadi, Francis K. ;

Kumar, Shaji K. .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (02) :215-217

[5] Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma [J].

Kumar, Shaji ;

Kaufman, Jonathan L. ;

Gasparetto, Cristina ;

Mikhael, Joseph ;

Vij, Ravi ;

Pegourie, Brigitte ;

Benboubker, Lofti ;

Facon, Thierry ;

Amiot, Martine ;

Moreau, Philippe ;

Punnoose, Elizabeth A. ;

Alzate, Stefanie ;

Dunbar, Martin ;

Xu, Tu ;

Agarwal, Suresh K. ;

Enschede, Sari Heitner ;

Leverson, Joel D. ;

Ross, Jeremy A. ;

Maciag, Paulo C. ;

Verdugo, Maria ;

Touzeau, Cyrille .

BLOOD, 2017, 130 (22) :2401-2409

[6] International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma [J].

Kumar, Shaji ;

Paiva, Bruno ;

Anderson, Kenneth C. ;

Durie, Brian ;

Landgren, Ola ;

Moreau, Philippe ;

Munshi, Nikhil ;

Lonial, Sagar ;

Blade, Joan ;

Mateos, Maria-Victoria ;

Dimopoulos, Meletios ;

Kastritis, Efstathios ;

Boccadoro, Mario ;

Orlowski, Robert ;

Goldschmidt, Hartmut ;

Spencer, Andrew ;

Hou, Jian ;

Chng, Wee Joo ;

Usmani, Saad Z. ;

Zamagni, Elena ;

Shimizu, Kazuyuki ;

Jagannath, Sundar ;

Johnsen, Hans E. ;

Terpos, Evangelos ;

Reiman, Anthony ;

Kyle, Robert A. ;

Sonneveld, Pieter ;

Richardson, Paul G. ;

McCarthy, Philip ;

Ludwig, Heinz ;

Chen, Wenming ;

Cavo, Michele ;

Harousseau, Jean-Luc ;

Lentzsch, Suzanne ;

Hillengass, Jens ;

Palumbo, Antonio ;

Orfao, Alberto ;

Rajkumar, S. Vincent ;

Miguel, Jesus San ;

Avet-Loiseau, Herve .

LANCET ONCOLOGY, 2016, 17 (08) :E328-E346

[7] PLASMA-CELL LEUKEMIA - REPORT ON 17 CASES [J].

KYLE, RA ;

MALDONADO, JE ;

BAYRD, ED .

ARCHIVES OF INTERNAL MEDICINE, 1974, 133 (05) :813-817

[8] Diagnosing and exploiting cancer's addiction to blocks in apoptosis [J].

Letai, Anthony G. .

NATURE REVIEWS CANCER, 2008, 8 (02) :121-132

[9] Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia [J].

Pan, Rongqing ;

Hogdal, Leah J. ;

Benito, Juliana M. ;

Bucci, Donna ;

Han, Lina ;

Borthakur, Gautam ;

Cortes, Jorge ;

DeAngelo, Daniel J. ;

Debose, LaKeisha ;

Mu, Hong ;

Doehner, Hartmut ;

Gaidzik, Verena I. ;

Galinsky, Ilene ;

Golfman, Leonard S. ;

Haferlach, Torsten ;

Harutyunyan, Karine G. ;

Hu, Jianhua ;

Leverson, Joel D. ;

Marcucci, Guido ;

Mueschen, Markus ;

Newman, Rachel ;

Park, Eugene ;

Ruvolo, Peter P. ;

Ruvolo, Vivian ;

Ryan, Jeremy ;

Schindela, Sonja ;

Zweidler-McKay, Patrick ;

Stone, Richard M. ;

Kantarjian, Hagop ;

Andreeff, Michael ;

Konopleva, Marina ;

Letai, Anthony G. .

CANCER DISCOVERY, 2014, 4 (03) :362-375

[10] Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting [J].

Richardson, Paul G. ;

San Miguel, Jesus F. ;

Moreau, Philippe ;

Hajek, Roman ;

Dimopoulos, Meletios A. ;

Laubach, Jacob P. ;

Palumbo, Antonio ;

Luptakova, Katarina ;

Romanus, Dorothy ;

Skacel, Tomas ;

Kumar, Shaji K. ;

Anderson, Kenneth C. .

BLOOD CANCER JOURNAL, 2018, 8

← 1 2 →